Blue Sky Capital Consultants Group, Inc. Moderna, Inc. Transaction History
Blue Sky Capital Consultants Group, Inc.
- $199 Billion
- Q2 2025
A detailed history of Blue Sky Capital Consultants Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Blue Sky Capital Consultants Group, Inc. holds 16,354 shares of MRNA stock, worth $427,166. This represents 0.23% of its overall portfolio holdings.
Number of Shares
16,354
Previous 15,119
8.17%
Holding current value
$427,166
Previous $429 Million
5.27%
% of portfolio
0.23%
Previous 0.28%
Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
854Shares Held
253MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$668 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$577 Million0.48% of portfolio
-
State Street Corp Boston, MA17.8MShares$464 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$232 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...